Skip to content

Clinical and Patient Outcomes of 4 mm Ultra-Short vs. 8 mm Implants With Bone Augmentation in the Back Upper Jaw

Clinical- and Patient-related Outcomes of 4 mm Ultra-short Implants Compared to 8 Mm-long Implants With Bone Augmentation for the Rehabilitation of Posterior Atrophic Maxilla: a Randomized Controlled Clinical Trial.

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07417293
Enrollment
35
Registered
2026-02-18
Start date
2026-02-20
Completion date
2029-07-01
Last updated
2026-02-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Posterior Atrophic Maxilla

Brief summary

This study aims to compare 2 different groups of patients with both a healed site in the upper posterior sector after extractions, one treated with ultra-short implants, and another with long implants with bone regeneration. The objective is to evaluate if short-implants are superior in terms of better clinical outcomes, survival rates and safety, reduced surgical time, postoperative discomfort, and complication risk compared to conventional implants and bone regeneration.

Interventions

DEVICEUltra short implants

Placement of an ultra short implant of 4mm in the posterior atrophic maxilla without any bone regeneration procedure

DEVICELong implants with bone augmentation

Placement of long implants of 8mm in the posterior atrophic maxilla alongside bone augmentation

Sponsors

Universitat Internacional de Catalunya
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Inform consent signed. * Adult patients (≥18 years old). * No pregnant women or without the desire to stay. * Periodontal and peri-implant health in a pristine or reduced periodontium. * Full mouth plaque score \< 20% (O'Leary, 1972) * Maxillary multiple posterior maxillary healed sites at least 4 months after extraction (with antagonist teeth with a good prognosis (Lindhe et al. 2008)) presenting ≥ 6.5 mm of bone width and 5-6 mm in height from the bone crest to the floor of the sinus. * Need for a multiple splinted implant supported restoration with distal adjacent teeth or distal free-end in the posterior maxilla

Exclusion criteria

* Patients with uncontrolled systemic diseases. * Smoker patients (≥10 cig/day). * Patients taking medications that affect bone metabolism or immunologic disorders. * Patients allergic to penicillin. * Patients presenting acute or chronic maxillary sinus lesions. * Advanced vertical crestal bone atrophy in the posterior maxilla (Type V and IV, Cawood-Howell Classification) * Vertical space of \< 6 mm for a screw-retained implant restoration. * Patients referring allergy to titanium or to any component of the implant/restoration. * No previous attempts of implant installation in the same surgical site. * Pregnant or lactating women. * Patients willing to start or in course of an orthodontic therapy.

Design outcomes

Primary

MeasureTime frameDescription
Satisfaction of the surgical procedureThe day of the intervention after the surgery is finalizedThe patient is gonna make a subjective assessment of satisfaction of the surgery once it is finished. For that, we are going to use a 10 centimeter visual analog scale. The extremes of the scale are the extreme expressions of satisfaction, where the extreme left represents a 0 (not satisfied) and 10 (very satisfied). The patient won't have numbers between 0-10 so he will not be influenced by them. Wherever he marks, we will measure it and it will represent in centimeters how was his satisfaction

Secondary

MeasureTime frameDescription
Surgical timeat the day of the intervention, since the administration of the anesthesia until the placement of the last suture knotelapsed time since the administration of local anesthesia until the placement of the last suture knot, with a scale of the exact minutes
Pain IntensitySince the day of the intervention once the surgery is finalized , until the 7th day after the surgery, each day of the following 7 daysSubjective assessment of pain intensity using a 10-cm visual analog scale. The extremes of the scale are the extreme expressions of pain
Rescue medicationAfter the surgery during the next 7 daysThe need to intake rescue medication of Ibuprofen 600mg, Paracetamol 650mg or Amoxicilin 500mg with a nominal response of Yes or No
Intra-surgical complicationsThe day of the surgeryAny undesired event that happens during the surgical procedure, for example, profuse bleeding, Schneider membrane perforation, by a categorical nominal answer Yes or No
Post-surgical complications7 days after the surgeryAny undesired event that happens during the first week of healing
Implant survivalFrom 10 weeks after surgery to 36 months, after restoration deliveryIf the implant is present in the mouth regardless of the biological or technical complications. An implant will be considered as failed if explantation is needed for the following reasons: (i) lateral, vertical mobility or rotation; (ii) drastic decrease in the ISQ values over time; (iii) discomfort or pain; and (iv) peri-implant radiolucency compatible with fibrointegration. It will be evaluated in a categorical nominal answer Yes or No
Marginal bone level changesThe day of the surgery, 12 months after and 36 months afterdistance from the mucosal margin to the base of the peri-implant pocket as measured with a PCP UNC 15 periodontal probe. By a mm scale
Probing pocket depth12 months after surgery and 36 months after surgerydistance from the mucosal margin to the base of the peri-implant pocket as measured with a PCP UNC 15 periodontal probe. Scale in mm.
Bleeding on probing12 months and 36 months after surgery: presence or absence of bleeding when performing the peri-implant probing. By a categorical nominal answer Yes or No
Suppuration on probing12 months and 36 months after surgeryPresence or absence of suppuration when performing the peri- implant probing. By a categorical nominal answer Yes or No
Keratinized mucosa width12 months and 36 months after surgerydistance from the mucogingival line to the peri-implant mucosal margin in the buccal site as measured with a PCP UNC 15 periodontal probe. In a mm scale
Soft tissue dehiscence12 months and 36 months after surgeryexposure of any of the abutment or implant components, by a categorical nominal answer Yes or No
Prosthetic complications12 months and 36 months after surgeryAny undesired event in the prosthetic component (abutment or crown), for example, screw loosening, ceramic chipping

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 19, 2026